Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference

Globe NewswireSep 10 16:05 ET

TD Cowen Maintains Artiva Biotherapeutics(ARTV.US) With Buy Rating

Moomoo NewsSep 3 06:31 ET · Ratings

Wedbush Maintains Artiva Biotherapeutics(ARTV.US) With Buy Rating, Maintains Target Price $18

Moomoo NewsAug 30 10:31 ET · Ratings

Artiva Biotherapeutics, Inc. (ARTV) Receives a Buy From Wedbush

TipRanksAug 30 10:05 ET · Ratings

Needham Maintains Artiva Biotherapeutics(ARTV.US) With Buy Rating, Maintains Target Price $23

Moomoo NewsAug 30 09:32 ET · Ratings

Buy Rating Affirmed for Artiva Biotherapeutics Amidst Clinical Advancements and Strong Financials

TipRanksAug 30 09:25 ET · Ratings